Introduction
Studies examining the relation between heart failure (HF) and prolongation of central circulation transit time (TT) have produced an extensive body of literature which spans nearly a century. [1] [2] [3] [4] [5] [6] [7] [8] [9] In contrast to the invasive evaluation referred to in classic literature, [1] [2] [3] [4] [5] [6] [7] [8] [9] non-invasive modalities have dominated the assessment of central TT in the modern era. [1] [2] [3] [4] [5] [6] [7] [8] [9] What remains consistent in this extensive body of work is that TT prolongation or delay is associated with the dilated and or functionally impaired left ventricle (LV) in patients with HF. Classic as well as contemporary literature primarily assesses the global central circulation TT between large vessels. Little is known about the regional circulation TT that takes place between individual central cardiovascular structures in HF. More importantly, there is a lack of comprehensive understanding of the circulation TT delay in HF patients with preserved ejection fraction (HFpEF). Our previous work has focused on prolonged regional mean TT in left atrium which is closely associated with increased left ventricular end diastolic pressure. 10 It is unclear, however, of the relation between global central
TT and left and right heart haemodynamics in patients with HF.
In this study, we sought to assess global and regional central circulation TT by analysing the gadolinium contrast dynamic kinetics of the first pass perfusion magnetic resonance imaging (MRI) in HFpEF patients and in HF patients with reduced EF (HFrEF) their relations to left and right heart haemodynamics in a subgroup of patients undergoing heart catheterization.
Methods

Participant recruitment
This was a prospective study approved by the institutional review board and written informed consent was obtained from all participants. The study cohort consisted of 48 HF patients and 10 normal volunteers. A subset of 28 HF patients underwent clinically indicated left and right heart catheterization on the same day of the research cardiac magnetic resonance imaging (CMR). There was no significant haemodynamic instability during the time interval among the participants. We reported comparable haemodynamics during catheterization and CMR in our previous publication. 10 ; claustrophobia; pacemaker/defibrillator implantation, or other metallic hazards. All participants completed a questionnaire of demographic information and past medical history. Clinical charts were reviewed to confirm cardiovascular history for all subjects.
Imaging protocol by MRI
All participants underwent CMR in a 1.5 T Avanto scanner (Siemens, Malvern, PA, USA) with an 8-element phased array surface coil. Cardiac volumes and systolic function were assessed using balanced steady-state free-precession (SSFP) cine imaging with retrospective ECG gating. Images were acquired during breath-hold in a stack of short axis views (8 mm thickness with 2 mm gap) and 3 long axis views (2, 3, and 4 chamber views) with the following parameters: echo time (TE) 1.3 ms, repetition time (TR) 3.1 ms, flip angle 70 , and average in-plane resolution 1.3 Â 1.3 mm 2 . To determine central circulation TT, first pass perfusion images were acquired every cardiac cycle over 50 up to 100 cardiac cycles during a bolus infusion of gadopentetate dimeglumine (Magnevist, Schering AG, Berlin, Germany) (0.01 mmol/kg) at a rate of 6 mL/s followed with a 15 mL saline flush. The first pass perfusion protocol consisted of an ECG gated 2D saturation recovery SSFP sequence with an inversion time of 90 ms, average field of view of 500 mm, TE 0.92 ms, and flip angle 50
. Parallel imaging was applied with an acceleration factor of 2. The total acquisition window was 480 ms with 160 ms per slice including the inversion time for an acquisition of 3 imaging planes. The perfusion images were acquired in 15 mm thickness in a sagittal view where the main pulmonary artery (PA), right ventricle (RV), and left atrium (LA) were well defined and in coronal views where the right atrium (RA), LV, and ascending aorta (AO) were well visualized ( Figure 1 ).
Image analysis
LV and RV end diastolic volume, end systolic volume, EF, and myocardial mass were assessed from CMR images using MASS software (Medis, Leiden, Netherlands). LA volume was assessed using the biplane arealength method as 0.85 Â A1 Â A2/L where A1 and A2 were the areas by planimetry in the 4 and 2 chamber views and L was the left atrial length perpendicular to the mitral annular plane in the 4 chamber view. Measurements were normalized to body surface area. Gadolinium contrast kinetics of the first pass perfusion image series was analysed to evaluate central circulation TT using MASS software. Small circular regions of interest were placed at a phase where anatomic structure was best defined by the contrast enhancement, then propagated through all image series acquired to assess serial contrast signal intensity and a graph of signal intensity over time constructed. TT was defined as the time between the peaks of time-intensity curves of the first pass ( Figure 2 ). All TTs were divided by RR duration for normalization because TT was correlated with heart rate. Global central circulation TT was defined as TT from RA to AO (at the level of main PA), while regional TT was defined as RA to PA, PA to LA, and LA to aorta as well as PA to AO.
Invasive haemodynamic testing by right and left heart catheterization
The right and left heart catheterization was performed under fluoroscopic guidance via a femoral vein and femoral artery, respectively following standard clinical protocols. Haemodynamic measurements included pressure recordings in RA, RV, PA, LV, and pulmonary capillary wedge (PCWP) position. In addition, blood oxygen saturation in PA and AO were measured and pulmonary and systemic vascular resistance determined. Haemodynamic tracings were recorded and stored electronically. Two experienced cardiologists reviewed tracings and the values of each haemodynamic measurement were determined by consensus.
BNP assays
A blood sample was collected for BNP or N-terminal proBNP (NT proBNP) prior to CMR for all study subjects. BNP was measured using a chemiluminescent microparticle immunoassay in EDTA plasma (ARCHITECT BNP assay by Abbott Laboratory, Abbott Park, IL, USA). NT proBNP was measured using an electrochemiluminescence immunoassay (Roche Diagnostics, Indianapolis, IL, USA).
Statistical analysis
Statistical analyses were performed using SPSS 16.0 for Windows (SPSS Inc., Chicago, IL, USA). The student t-test and Chi-square test were used to compare the continuous and categorical variables, respectively. Analysis of variance was used to compare means among normal and HF groups. Non-parametric tests (Kruskal-Wallis and Mann-Whitney U) were used to compare the median values of BNP and NT-proBNP. Pearson correlation was performed to assess the associations of global central TT with cardiac volume, EF and haemodynamic indices. P-values were adjusted by Bonferroni correction for multiple testing. Multivariate linear regression was used to test the relation of central TT with covariates using stepwise selection with P < 0.05 to enter. Two-tailed P-value < 0.05 was considered statistically significant for all analyses.
Results
Of the 58 participants, 10 were in normal control group, 20 in HFpEF, and 28 in HFrEF group. HFpEF patients were older, more likely to have smoked and to have hyperlipidaemia compared to HFrEF patients ( Table 1) . As expected, HFrEF Patients were associated with dilated cardiac chamber and reduced systolic function while HFpEF patients were not. The median level of BNP and NT-ProBNP was higher in HFrEF than in HFpEF patients.
Global central circulation TT from RA to AO was modestly correlated with heart rate (r = 0.263, P = 0.046) but not with body height (0.113, P = 0.400) or weight (r = 0.147, P = 0.271). Therefore Regional TT from RA to PA, PA to LA, and LA to AO was all prolonged in HF patients with the longest absolute delay of TT present in pulmonary vasculature (PA to LA) ( Figure 3) . Relative TT prolongation between PA to AO was similar to TT prolongation between RA to AO with 48% increase of TT in HFpEF and 105% increase in HFrEF compared to normal controls.
While global central TT was significantly correlated with all cardiac indices in univariate analysis, the correlation with LVEF and RVEF were the strongest (r = -0.737, P < 0.01 for both) ( Table 2 ) (Figure 4) . However, as shown in the scatter plot ( Figure 4 ) the correlation of global TT with LVEF was largely influenced by the cases with HFrEF in whom the correlation was strong (r = -0.649, P < 0.001). In contrast, the correlation was limited (r = -0.337, P = 0.146) in cases with HFpEF.
A subgroup of 28 HF patients underwent same day cardiac catheterization. Compared to HFrEF without cardiac catheterization (N = 16), HFrEF with catheterization (N = 12) were younger (52 ± 16 years vs 67 ± 13 years, P = 0.011) and had a trend of lower LVEF (25 ± 10% vs 31 ± 10%, P = 0.178) and lower RVEF (34 ± 15% vs 43 ± 11%, P = 0.095) In contrast, among patients with HFpEF, there was no significant difference in age (P = 0.427), LVEF (P = 0.380), and RVEF (P = 0.673) between patients with (N = 16) and without cardiac catheterization (N = 4). On average, haemodynamic abnormalities were more pronounced in patients with HFrEF than patients with HFpEF ( Table 3) . Global central TT prolongation was significantly associated with haemodynamic abnormalities such as elevated PCWP and LVEDP, reduced cardiac index, and oxygen saturation, (Table 4) , of which increased PCWP demonstrated the strongest association in univariate analysis (r = 0.680, P < 0.001) ( Figure 5) .
Multiple multivariate regression analyses were performed in three models to identify the correlates of global central TT. Covariates including PCWP, LVEDP, PA oxygen saturation, cardiac index by Fick method, LVEF, and RVEF were adjusted in each of the three models. RVEF and PCWP were identified as the most significant correlates of global central TT in Model 1 which included all subjects undergoing cardiac catheterization ( Table 5 ). In the subgroup analysis, PCWP and PA oxygen saturation were the most important correlates of global central TT in HFpEF (Model 2) in comparison with LVEF and RVEF in HFrEF (Model 3).
Discussion
We assessed global circulation TT as well as regional TT amongst central cardiovascular structures by analysing contrast dynamic The interest of assessing central circulation TT stemmed from the early days of heart catheterization and the establishment of the indicator dilution principle. 11, 12 Classic and contemporary literature have established the link between prolonged TT with dilated LV, reduced LV systolic function, 3, 7, 13 and in HF patients with low-cardiac output. 2, [4] [5] [6] [7] We confirmed all these findings in our study. We also found that the most significant determinants of prolonged global TT in multivariate analysis proved to be reduced RVEF and elevated PCWP, thereby suggesting an important role of haemodynamic abnormality in central TT prolongation among patients with left HF. Additionally, we extended our observation to patients with HFpEF in whom prolonged central TT was only associated with haemodynamic abnormalities but not with LVEF. While it is important to understand the association of global TT with haemodynamics in HFpEF it is also essential to recognize that the association of global TT and EF in HFrEF is not independent of haemodynamics because EF is a load sensitive measure in patients with HFrEF.
To date, few studies have investigated central TT in patients with HFpEF, a population with growing clinical importance. We demonstrated that elevated PCWP and reduced oxygen saturation are the most important indices in association with prolonged central TT in subjects with HFpEF, a finding that provides new insight to the HFpEF pathophysiology in association with central TT prolongation. Our findings suggest that prolonged central TT in patients with preserved EF may possibly differentiate patients with and without HF. It may effectively compliment the functional assessment and tissue characterization by CMR.
Thus far, central circulation TT is largely measured between large vessels, from PA to aorta 7, 8 , PA to femoral artery 3 , PA to LA 2 , or antecubital vein to peripheral tissues. 4, 14, 15 These are primarily designed to evaluate global central TT but not regional TT. While all regional TT assessed were prolonged in HF patients, regional TT from PA to aorta showed the closest proportion of TT prolongation to global TT from RA to AO in HF patients. Early studies have made attempts to differentiate right and left side circulation TT by comparing lung-to-tongue and arm-to-tongue TT [16] [17] [18] whereby concluding that isolated left HF is associated with TT delays only in the left heart but not in the right heart. These estimates, however crude, suggest possible clinical value of regional TT assessment. As early as in 1928, Blumgart and Weiss have speculated that pulmonary circulation is the likely site of delay in central circulation TT in patients with cardiovascular disease. 1 By assessing regional TTs comprehensively we were able to provide direct evidence proving that pulmonary circulation plays a key role in central TT delay. It is worth noting that the assessment of regional TT is not limited to the peak-to-peak TT from one region to the other. Recent publications 8, 19, 20 demonstrate the haemodynamic importance of mean TT within right or left heart in right and left HF, respectively. These findings and ours all support the important relation of regional circulation TT to haemodynamics. Until the rise of contemporary technologies such as nuclear [21] [22] [23] and computed tomography, 9, 24 7, 8 which is effective in assessing global TT between large vessels but is limited in delineating regional TT due to poor cardiac chamber definition caused by the use of volume rendering and non-ECG-gated acquisition. In this study we chose 2D SSFP dynamic sequence because of its excellent contrast to noise ratio 25 which is superior to the gradient echo sequences found in 3D acquisitions. In addition, the ECG gating in the SSFP 2D acquisition allowed us to measure dynamic signals in any cardiovascular structure with limited cardiac motion. Lastly, the contrast used in our study was on average 1-2 mL which is much smaller than the contrast needed for a standard 3D MRA. The small dose makes it feasible to add the dynamic imaging to any standard protocol or to perform serial acquisitions. We recognize the study limitations. Our patient population primarily consists of those with left HF. Therefore, findings cannot be extrapolated to those with pure right HF. Coexisting pulmonary disease may also complicate central TT assessment, given that mean pulmonary TT is prolonged in patients with primary pulmonary hypertension 26 and in patients with advanced lung disease 8 . Lastly, the predictive value of central circulation TT with regard to clinical outcome is yet to be investigated.
To conclude, central circulation TT is not only prolonged in patients with HFrEF but also in patients with HFpEF. Regional TT delay in pulmonary vasculature accounts for the longest absolute delay of global TT prolongation in HF patients. While reduced cardiac function is the determinant of prolonged central TT in HFrEF, haemodynamic abnormalities have proved to be the essential correlates of prolonged TT in HFpEF. Our findings underscore the importance of haemodynamic abnormality in central TT prolongation in HF patients. 
